IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 113 filers reported holding IGM BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 4.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,509,000 | -48.2% | 22,952 | -34.4% | 0.19% | -53.3% |
Q2 2021 | $2,913,000 | +7.2% | 35,012 | -1.2% | 0.41% | +4.3% |
Q1 2021 | $2,717,000 | +40.5% | 35,434 | +61.8% | 0.39% | +25.6% |
Q4 2020 | $1,934,000 | -30.6% | 21,900 | -42.0% | 0.31% | -46.5% |
Q3 2020 | $2,785,000 | +102.1% | 37,737 | +100.0% | 0.58% | +99.0% |
Q2 2020 | $1,378,000 | – | 18,873 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |